Skip to content

Port Access AN162075Recalls & reported problems

Bard Access Systems, Inc. · AllPoints Port Access System SafeStep 20G x 0.75 inch · Class 2

All models of Port Access (11)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
0
Recalls naming it
1

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00801741119675), received between May 21, 2022 and May 1, 2026 — classified as 3 malfunctions.

The most frequently reported specific device problem is “Activation Problem” (2 reports).

1 FDA recall record name this device's identifier.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 2 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Recalls naming this device

  1. Jun 19, 2020Terminated

    Potential development of cracks or breaks in the tubing near the Luer or Y site of the device. Devices that have developed breaks or cracks can cause leakage resulting in exposure to chemicals such a chemotherapeutics or biohazard material (e.g., blood). A crack or break could result in potential blood loss, catheter occlusion, air embolism, under or interrupted infusion, or site contamination which could lead to infection.

    Z-2664-2020 · Root cause: Process control · Recall details · FDA record ↗

Most reported problems

Device problems

  • Activation Problem2
  • Fluid/Blood Leak1

Patient problems

  • No Clinical Signs, Symptoms or Conditions3

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMay 1, 2026Activation Problem

    IT WAS REPORTED BY THE CUSTOMER THAT SAFESTEP 20G X 0.75IN HUBER NEEDLE WOULD NOT ENGAGE THE SAFETY MECHANISM. NO FURTHER INFORMATION WAS PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25057268 ↗
  • MalfunctionMay 1, 2026Activation Problem

    IT WAS REPORTED BY THE CUSTOMER THAT SAFESTEP 20G X 0.75IN HUBER NEEDLE WOULD NOT ENGAGE THE SAFETY MECHANISM. NO FURTHER INFORMATION WAS PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25056829 ↗
  • MalfunctionMay 21, 2022Fluid/Blood Leak; Fluid/Blood Leak

    IT WAS REPORTED "FOUND A PORT NEEDLE THAT LOOKS LIKE THE PLASTIC HOUSING IS CRACKED. IT WAS LEAKING BOTH BLOOD AND FLUIDS UPON FLUSHING AND ASPIRATION." ADD INFO RCVD 05/11/2022: WAS THE PRODUCT USED ON A PATIENT? YES. WAS THERE ANY PATIENT HARM REPORTED? NO.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14465991 ↗

Other Set, administration, intravascular devices

All Set, administration, intravascular devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page